In a former communication ( I ) we reported that the action of ethylhydrocuprein (a derivative of hydroquinine introduced by Morgenroth and Levy (2)) was well marked in vitro and in vivo on type strains of the four groups of pneumococci. Since we possess in certain types of antipneumococcus serum the means of conferring on experimental animals considerable specific protection against very many multiples of the minimal lethal dose of a virulent pneumococcus culture, it seemed to us of interest to study the combined effect of chemo-and serotherapy in vivo, and to endeavor to get some numerical values representing the results. Neufeld (3) showed that strains of pneumococci differed among themselves in respect to their immunity reactions (protective antibodies).
The work of Cole (4) and of Dochez and Gillespie (5) has resulted in a serological classification of the pneumococci. The pneumococci can be divided into at least four groups; an immune serum produced against any member of Group I has a specific agglutinative action upon, and a specific protective action against, any member of Group I, but has no such effects on any member of the other three groups. In like manner, an immune serum against any member of Group II behaves similarly with respect to any member of Group II, but has no effect on any member of Groups I, III, or IV. To Group III belong all the microorganisms of the Pneumococcus mucosus type. To Group IV belong all those strains of pneumococci which do not fall into the other three groups ; an immune serum produced against any member of this group has a specific agglutinative action upon, and a specific protective action against, the strain used for its production, but has no such effects on any other member of this group, or of the other groups.
Neufeld and Engwer (6) and Engwer (7) have studied the effect of combining the serum and chemotherapy in guinea pigs infected with pneumococcal pleural exudates; these observers saw an increased effect by the combination. Their protocols do not show, however, to what group either the pneumococcus or antiserum belonged; it is not clear whether or not the antiserum used was produced against a member of the group to which the infecting pneumococcus belonged. Boehncke (8) , too, saw a markedly increased effect in mice by the combination of serum and drug therapy over and above the effect of either of these two separately; in the protocols of his experiments, also, we have little information as to the group to which the pneumococct~s or antiserum belonged.
We deemed it of importance to study the results of combined chemotherapy and serum therapy in the light of the serological classification of the pneumococci mentioned above; and, since the results of serum therapy in man have not been at all as satisfactory in the case of lobar pneumonia due to pneumococci belonging to Group II as when the disease is caused by a strain of Group I, we have given the greater part of our attention, in this respect, to infection with pneumococci belonging to Group II. Further, the threshold value of our immune horse serum to Group I is more than ten times greater than the corresponding serum to Group II. Hence a satisfactory result with an antiserum to Group II should mean an even better result with an antiserum to Group I, in the case of infection with a strain of the homologous group.
Since toxic symptoms have been several times noticed in human patients and in experimental animals treated with ethylhydrocuprein, we have endeavored to reduce to a minimum the amount of ethylhydrocuprein given to the animals in the present study. The dose of ethylhydrocuprein (optochin base) recommended by Morgenroth (9) in experimental pneumococcal infection in the mouse is o.5 cc. of a 2 per cent solution in olive oil given under the skin of the back immediately following the infection, and repeated on the next day; this is followed on the third day, and on the fourth day if desirable, by a similar injection of o.4 cc. of the same solution. The dosage used in the present study is considerably below this. The experimental animals used were mice.
EXPERIMENTAL.
The strain of pneumocoecus of Group II used in the present study was a stock strain and was maintained in a condition of maximal virulence throughout the experiments ; that is to say, o.ooo,ooi cc. of a twenty hour broth culture regularly killed mice within forty-eight hours. Several controls of virulence were done in the case of each experiment. A twenty hour broth culture of the pneumococcus was used in every case. In the designation of the culture, the Roman numeral represents the group to which the pneumococcus belongs, the Arabic figure the number of animal passages which the strain had had, and the exponent the number of cultivations on artificial media since the last animal passage.
Mice of 18 grams' weight and upwards were used; the dosage of the drug was calculated in every case according to the weight of the animal. An autopsy was performed on every mouse that succumbed, unless otherwise stated in the protocols (owing to the body having been eaten by the survivors).
A constant amount of immune horse serum, o.2 cc., was used in the experiments; it was mixed with the infecting dose of culture, and the mixture, making a total volume of I cc., was given intraperitoneally.
The ethylhydrocuprein (optochin base) was administered in the form of a 2 per cent solution in olive oil, given under the skin of the back. This treatment was given, in the first instance, immediately Result.
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• , 6 after the infection; if a second dose was given it was given after an interval of 24 hours. In the protocols the letter S stands for survival of the corresponding animal; a black square (m) means death of the animal from pneumococcal septicemia, capsulated diplococci having been found in its .heart's blood 'by His's capsule stain, or, if this examination proved negative, Gram-positive diplococci having been recovered by culture (abundant inoculation on defibrinated rabbit blood agar) from the heart's blood at autopsy. An oblique cross (X) means death of the animal, the bacteriological examination of the heart's blood (and peritoneal cavity, if necessary) by smear and culture being negative; in this case the death of the animal may have been due to fortuitous influences, the toxicity of the drug, traumatism inflicted in the experiment, etc. When an autopsy was not possible on an animal, its death is indicated by the sign +.
Comment on Experiment ~r.--From the protocol it is seen that, while the intraperitoneal injection of 0.2 cc. of antipneumococcus serum II gives to mice a sure protection against o.ooi cc. of a virulent culture (Strain II 425), this amount of serum only gives a very doubtful protection against o.oi, 0.02, and o.04 cc. of culture, and none at all against 0.06 cc. or more. • 24 hrs.
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C¢. Comment on Experiment 4.--In this experiment in which a larger dose of infection was given than in Experiment 3 the results did not come out uniformly or clear. The majority of the animals died, although in most cases death was delayed. We thought that a small dose of optochin given on the second day might serve to tide the animals over the third and fourth days and so help ultimate re-covery; the result of this modification in dosage of the drug is shown in the next experiment. Virulence controls were done, as in Experiment 3 a, but are not shown in the table. Comment on Experiment 5.--5 ° per cent of the animals infected with 0. 3 cc. of culture, and treated as stated, survived; of those that died, pneumococci were not recovered from the heart's blood of one; one was eaten by its fellows and could not, therefore, be autopsied; two gave positive blood cultures. In the case of infection with 0.5 cc. of culture, only two animals recovered; pne umococci were recovered from the heart's blood of all those that died except one, the body of which was so far eaten that it could not be bacteriologically examined. In this experiment the altered dosage of the drug ensured a better result than in the former case, but it is evident that we are at the limit of protective power for the conditions obtaining therein. Consequently we proceeded to study the effect of a single larger dose of drug combined with the serum therapy; namely, 0. of culture, and treated as stated, survived. The four mice which died were eaten by their fellows and therefore could not be autopsied; in three of these cases death was delayed (fourth and fifth days). Of the nine animals infected with 0.4 cc. of culture, six survived; one died on the second day with a sterile heart's blood (abundant inoculation) but pneumococci were recovered from the peritoneal cavity; one died on the fourth day and showed a sterile heart's blood on cultivation; and one was eaten by its fellows on the seventh day. The thirteen controls infected with o.o8 cc. of culture and treated with the dose of drug used in the actual experiment all died in forty-eight hours, pneumococci being present in the heart's blood of all. These controls are not shown in the protocol. 
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Three virulence controls (O.OOOOOI CC.) all died in forty-eight hours of pneumococcal septicemia.
Comment on Experiment 7.--All the animals infected with 0.4 cc. of culture and treated, and all but one infected with 0. 5 cc. of culture and treated, survived; from the heart's blood of the one which died (fourth day) pneumococci were recovered. 5 ° per cent of those infected with 0.6 cc. of culture and treated survived; the remainder died of pneumococcal septicemia (third tc fifth day). We have here, evidently, reached the limit of protection to be gotten by the simultaneous administration of antiserum and drug in the manner and quantities indicated above.
In addition to the experiment mentioned above, we have carried out a series of experiments in which the mice were treated with ethylhydrocuprein and a non-homologous serum. For example, we have used an antiserum to pneumococcus of Type I in the case of infection with from o.oooI cc. to o.x cc. of a broth culture of a virulent pneumococcus of Type II (Strain II 342°), the minimal lethal dose of which was o.oooooI cc. ; and we have given the ethylhydrocuprein solution both as one dose (o. 5 cc.) at the time of infection, and as three doses on the three first days of the experiment (o.25 cc., o.25 co., and o.z co.), the administration of the first dose following the infection immediately; by thus combining the drug treatment with non-homologous serum therapy, we have seen no effect such as we have described above when the serum was homologous. Again, in the case of treatment of infection with a virulent strain of Group IV (Strain IV A 67.II3), the minimal lethal dose of which was o.oooooI cc., we have had no such success on giving the drug and a potent antiserum to pneumococci of either Group I or Group II. The protocols of these experiments need not be exhibited.
DISCUSSION OF RESULTS.
The results of this study of the treatment of experimental pneumococcal infection in the mouse by simultaneous administration of ethylhydrocuprein and antipneumococcus serum are clear. The protocols show that o. 5 co. of a 2 per cent oily solution of ethylhydrocuprein (optochin base), or o.2 ce. of the type homologous antiserum, are each, by themselves, powerless to protect against o.o6 ce. of a highly virulent culture of a pneumococcus of Group II; but that if both these bodies, which are chemically far removed from each other, be exhibited simultaneously, protection is given to the animal against as large a dose of infection as o. and out of all proportion to, the protective value of either alone. The preceding epitome of the results (Table IX) will make this clear.
It is important to note that, where a non-homologous antiserum is used in this combined method, e. 9., a Type I antiserum with a pneumococcus of Group II or a Type I or II antiserum with a pneumococcus of Group IV, no such effect as that just stated is seen. Indeed, no more effect is obtained than if normal, and not immune, serum be used. It seems that, if the dose of ethylhydrocuprein given in the first instance be below a certain quantity in relation to the amount of the infection, subsequent readministration of the drug on the next day is powerless to prevent a fatal result from pneumococcal septicemia.
CONCLUSIONS.
I. A single small dose of ethylhydrocuprein (optochin base), which by itself has practically no protective effect against experimental pneumococcal infection in mice, is capable of increasing the threshold value of the type homologous antipneumococcus serum at least fifty times.
2. This effect is proportionately many times greater than a simple summation of the protective effects of these two bodies.
3-No such effect is obtained when the antiserum used is one produced against a strain of pneumococcus from a group other than that to which the infecting pneumococcus belongs.
